Clinical trial
IGF1 Generation Test
NCT00145457 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00145457 |
|---|---|
| Title | IGF1 Generation Test |
| Official title | A Multicentre Study on the Capacity of the IGF-1 Stimulation Test to Predict the Growth Promoting Effect of Standard and High Doses of Genotonorm® in Prepubertal Children With Growth Hormone Deficiency. |
| Acronym | CAREL |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Growth Hormone Deficiency |
| Intervention type | Procedure |
| Interventions | Blood sample, Radiography |
| Enrollment | 82 |
| Start date | Apr 1, 2001 |
| Completion | Jan 1, 2005 |
| First posted | Sep 5, 2005 |
| Last update posted | Jun 6, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: